CXBS (Corix Bioscience) Other Operating Expense: $0.16 Mil (TTM As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Corix Bioscience Other Operating Expense?

Corix Bioscience CXBS -99.00% Other Operating Expense is $0.16 Mil as of Sep. 2017.

Corix Bioscience's Other Operating Expense for the three months ended in Sep. 2017 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2017 was $0.16 Mil.

Corix Bioscience's quarterly Other Operating Expense declined from Mar. 2017 ($0.00 Mil) to Jun. 2017 ($0.00 Mil) but then increased from Jun. 2017 ($0.00 Mil) to Sep. 2017 ($0.00 Mil).

Corix Bioscience's annual Other Operating Expense stayed the same from Jan. 2014 ($0.00 Mil) to Jan. 2015 ($0.00 Mil) but then increased from Jan. 2015 ($0.00 Mil) to Dec. 2016 ($0.16 Mil).

Corix Bioscience Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Other Operating Expense Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Other Operating Expense
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.16

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.16 0.00 0.00 0.00

Corix Bioscience Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.16 Mil mean?
Corix Bioscience (CXBS) has a Other Operating Expense of $0.16 Mil as of Sep. 2017. Other operating expenses that a company records on its income statement. View historical data on Corix Bioscience and its competitors.
Is Corix Bioscience's Other Operating Expense too high?
Corix Bioscience's current Other Operating Expense is $0.16 Mil.
How does Corix Bioscience's Other Operating Expense compare to BKIT and YBAO?
Corix Bioscience's Other Operating Expense of $0.16 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Corix Bioscience and its competitors. Corix Bioscience's current Other Operating Expense is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Other Operating Expense of $0.16 Mil. The current Other Operating Expense is $0.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Other Operating Expense is $0.16 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.